Symptom Checker AI vs Isomorphic Labs

Side-by-side comparison of features, pricing, and ratings

Analysis reviewed Live tool data as of 2026-10-09
Cross-checked through our multi-step verification ·
Saved

At a glance

DimensionSymptom Checker AIIsomorphic Labs
PricingFreeContact (enterprise pricing)
Target UsersStudents, educators, curious individualsPharma companies, large-scale drug programs
Core AI CapabilityAI symptom analysis via ChatGPTPredictive & generative AI for drug discovery
ValidationExperimental, not reviewed; educational onlyBuilt on Nobel Prize-winning AlphaFold; pharma partnerships
ScaleIndividual useEnterprise collaborations with multi-billion dollar pharma

These tools operate in entirely different universes. Symptom Checker AI is a free, experimental student project for learning about AI limitations in healthcare — never for real diagnosis. Isomorphic Labs is a deep-tech drug discovery powerhouse backed by DeepMind, with $600M in funding and partnerships with Novartis and Johnson & Johnson. Choose Symptom Checker AI for casual exploration or education; choose Isomorphic Labs only if you're a pharma company seeking AI-driven molecule design at scale.

Symptom Checker AI
Symptom Checker AI

A free, student-made AI symptom checker built as an educational demo, not a medical tool.

Visit Website
Isomorphic Labs
Isomorphic Labs

Isomorphic Labs applies generative AI drug discovery to design novel molecules and predict how candidates will perform.

Visit Website
Pricing
Free
Contact Sales
Plans
$0/mo
—
Popularity
5 views
7.5k views
Skill Level
Beginner-friendly
Advanced
API Available
Platforms
Web
—
Categories
🏥 Healthcare
🧬 Drug Discovery & Life Sciences
Features
Free symptom submission with no account required
Structured input form covering main symptom and details
Free-text symptom description field (onset, severity, changes)
Age and gender selection
Relevant health issues and surgeries field
Social history field (smoking, alcohol, recreational drug use)
Current or recently used medications field
Relevant test results field (laboratory, radiology, pathology, microbiology)
ChatGPT-generated response to submitted symptom data
Explicit on-page disclaimer that output is non-reviewed AI output
Emergency guidance directing users to contact a physician or dial 911
Start over function to clear and resubmit
Drug Design Engine spanning generative molecule design through lead optimization
Predictive AI models that anticipate how candidate drugs will perform
Generative models for designing novel molecules
Builds on and beyond the Nobel-winning AlphaFold system
End-to-end research collaborations from target identification to lead optimization
Digital biology approach aimed at discovery at digital speed
Named pharma partners include Johnson & Johnson, Novartis and Eli Lilly
Joined the Virtual Biology Initiative to build foundational data for AI disease models
Funder of Biohub's $1.8B initiative to train AI models that predict cell behavior
Bioresilience framework for biological threats and health emergencies
Series B investment round announced May 2026 to scale the Drug Design Engine
Follows a $600M external raise in March 2025
President Max Jaderberg appointed November 2025 to integrate AI and science
Interdisciplinary team of drug discovery experts and ML specialists
Founded by Demis Hassabis, who serves as CEO

Who should pick which

  • Student researching AI in healthcare
    Pick: Symptom Checker AI

    Free, transparently experimental, and designed for educational use. Lets students explore AI limitations without risk.

  • Big pharma R&D executive
    Pick: Isomorphic Labs

    Only Isomorphic Labs offers AlphaFold-powered predictive and generative models at enterprise scale, with proven pharma partnerships and massive funding.

  • Curious individual checking non-urgent symptoms
    Pick: Symptom Checker AI

    Free and easy to use, but must be strictly for curiosity only. No medical decisions should be based on it.

  • Drug discovery startup without pharma connections
    Pick: Symptom Checker AI

    Neither tool is suitable; Symptom Checker AI is not for drug discovery and Isomorphic Labs requires enterprise partnerships. Consider other options.

  • Educator demonstrating AI limitations
    Pick: Symptom Checker AI

    The tool's explicit disclaimers and structured but flawed output make it ideal for teaching critical evaluation of AI in medicine.

Frequently Asked Questions

Symptom Checker AI vs Isomorphic Labs: which should you choose?

These tools operate in entirely different universes. Symptom Checker AI is a free, experimental student project for learning about AI limitations in healthcare — never for real diagnosis. Isomorphic Labs is a deep-tech drug discovery powerhouse backed by DeepMind, with $600M in funding and partnerships with Novartis and Johnson & Johnson. Choose Symptom Checker AI for casual exploration or education; choose Isomorphic Labs only if you're a pharma company seeking AI-driven molecule design at scale.

Can Symptom Checker AI be used for actual medical advice?

No. It is explicitly experimental, student-made, and not reviewed by medical professionals. It should never replace professional medical advice.

Does Isomorphic Labs offer any free or self-service product?

No. It only operates through enterprise partnerships with pharma companies. There is no API, software, or public tool.

What recent funding has Isomorphic Labs secured?

A $600M external investment round in March 2025 and a Series B round in February 2026 (amount undisclosed).

Which tool uses AlphaFold?

Isomorphic Labs builds on DeepMind's Nobel Prize-winning AlphaFold system for its drug design engine.

Is Symptom Checker AI up to date?

There is no recent news; it remains an experimental tool based on ChatGPT with no clinical validation.

Can I use Isomorphic Labs for my academic research?

Only if your institution has a pharma partnership with Isomorphic Labs. Otherwise, access is restricted.

Which tool is better for learning about AI in healthcare?

Symptom Checker AI, due to its free access, transparency, and educational focus. Isomorphic Labs is not accessible for individual learning.

Has Isomorphic Labs partnered with any pharma company recently?

Yes, it entered a research collaboration with Johnson & Johnson in January 2026, in addition to its existing Novartis partnership.

More Symptom Checker AI or Isomorphic Labs comparisons

Explore each tool further

Browse these categories

Still deciding? Get the weekly AI tools brief

One email a week — new tools, honest comparisons, no spam.

Last reviewed: July 3, 2026